Butylidenephthalide

N/A

Report date: 2026/01/21 20:00:47
NME

Base Information

Drug NameButylidenephthalide
Drug Alias NameBdph-WaferBPz-butylidenephthaliden-butylidenephthalideBP/polymer wafer +[12] 
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase modulatorsNuclear receptor subfamily 4 group A member 1 modulatorsTelomerase inhibitors
TargetsAXL receptor tyrosine kinaseNuclear receptor subfamily 4 group A member 1Telomerase
Therapy Area/IndicationsAmyotrophic Lateral SclerosisGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEverfront Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverfront Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisGlioblastomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG